Pharmafile Logo

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down to “normal” levels until 2024. As a life science service provider working with companies across the world, we are seeing firsthand how some companies are already tightening their budgets in response to the ongoing economic uncertainty and other world events such as the war in Ukraine.

Inflation is impacting all aspects of in-person meetings

After 2+ years of COVID-19-imposed restrictions, many teams are itching to get back to in-person meetings. However, with flightgasoline, and food prices skyrocketing lately, in-person engagements are becoming more expensive and may not be the best “bang for your buck.” (That is, if your advisors and team members can even make it to the meeting on time amidst record flight cancellations and delays.)

The good news is that there are ways to beat inflation and still continue those vital engagements with your key stakeholders. Instead of relying only or mainly on in-person meetings for your advisory boardslearning programsco-author working groups, and internal corporate events, consider replacing some of these with inflation-neutral virtual engagements. Your customers’ needs have not gone away just because prices are up. If anything, it is more crucial than ever to gather insights from healthcare providers, payers, and patients on current market conditions

Read the rest of the article here to learn more!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The New Normal: Upcoming Trends in Clinical Trials

Samuel Searcy, Founder & CEO of CliniStart, shares his expert insights into trends, current gaps, and future predictions for clinical trials. Among many other things, we also dive into his...

Digitizing Cardiac Rehab to Capture and Retain More Patients

Dr. Harsh Vathsangam, CEO & Co-Founder of Moving Analytics, shares his expertise on mobile health and discusses how it can be used to improve patient adherence and access to cardiac...

Lesson Learned from the Pandemic

Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China and how that...

The Ongoing Evaluation of Medical Affairs

Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer, discusses a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work...

Innovation in Research, Digital Solutions and Patient Engagement

Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, talks about everything from his personal health journey to his...

Transforming Healthcare Through the Power of Patients

Esther Schorr, Co-founder and Chief Operating Officer of Patient Power LLC, discusses non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take...

Global Marketing, Technology, and Innovation

Jim Lefevere, Director of Global Marketing Services at Roche, discusses the changes in digital marketing strategies, workflow, team dynamics, and required skill sets among Pharma teams brought on by COVID-19....

Train Your Brain for Success

Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. He also delves into...

Amplifying Data Science Tools for End-to-End eClinical Solutions

Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing...

Virtual meeting technologies for reducing emissions and waste in the healthcare industry

Read the full article here or on the Green Business Bureau blog for more details.